Besides, only a few of them applied GnRH-antagonist protocol, which was reported to have lower risks of OHSS without significant difference in clinical pregnancy rate and live birth rate comparing to GnRH-agonist protocol for COH (17, 18). Here, GNRH1 is linked to ovarian hyperstimulation syndrome.